2 terminated, 2 unknown, 1 completed, 1 not yet recruiting. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Terminated 2, Unknown 2, Completed 1, Not yet recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Antiphospholipid Syndrome: new trials by email Literature Review of Antiphospholipid Syndrome trials Research Report on Antiphospholipid Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anticoagulant Cessation After Antiphospholipid Autoantibodies Loss in Thrombotic Antiphospholipid Syndrome Vitamin K Antagonist - Drug, Anticoagulant Therapy Discontinuation - Antiphospholipid Syndrome, Thrombotic Antiphospholipid Syndrome | Phase 3 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 234 | 2026-12-01 | 2026-10-15 |
| The BeLimumab Antiphospholipid Syndrome Trial (BLAST) Belimumab - Antiphospholipid Syndrome | Phase 2 / Phase 3 | Unknown | University of Turin, Italy | 15 | 2022-06-01 | 2023-01-13 |
| Hydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid Syndrome Hydroxychloroquine, Placebo - Primary Antiphospholipid Syndrome | Phase 3 | Unknown | University Hospital, Angers | 300 | 2018-08-15 | 2018-05-30 |
| Rivaroxaban in Thrombotic Antiphospholipid Syndrome Experimental: Rivaroxaban - Antiphospholipid Syndrome | Phase 3 | Terminated | University of Padova | 121 | 2014-12-01 | 2018-01-30 |
| Rivaroxaban for Patients With Antiphospholipid Syndrome Rivaroxaban, acenocumarol - Antiphospholipid Syndrome | Phase 3 | Completed | Hospital Universitari Vall d'Hebron Research Institute | 190 | 2013-03-13 | 2018-05-11 |
| Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients Hydroxychloroquine - Antiphospholipid Syndrome | Phase 3 | Terminated | Hospital for Special Surgery, New York | 11 | 2013-02-01 | 2021-09-14 |
Thrombosis (3) · Syndrome (1)
Autoimmune Diseases (6) · Immune System Diseases (6) · Cardiovascular Diseases (3) · Embolism and Thrombosis (3) · Vascular Diseases (3) · Disease (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Acenocoumarol (2) · Hydroxychloroquine (2) · Rivaroxaban (2) · belimumab (1) · fluindione (1)
Assistance Publique - Hôpitaux de Paris (1) · Hospital Universitari Vall d'Hebron Research Institute (1) · Hospital for Special Surgery, New York (1) · University Hospital, Angers (1) · University of Padova (1) · University of Turin, Italy (1)
France (2) · Italy (2) · Spain (1) · United States (1)
Cristina Belizna, MD, PhD (1) · Doruk Erkan, MD (1) · Josefina Cortes, MD,pHD (1)
PMID 30002145, PMID 37422199, PMID 40934736
2017 (1)